Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10013889HBVENSG00000012124.17protein_codingCD22NoNo933P20273
Q0EAF5
TVIS30082490HIVENSG00000012124.17protein_codingCD22NoNo933P20273
Q0EAF5
TVIS20009984HPVENSG00000012124.17protein_codingCD22NoNo933P20273
Q0EAF5
TVIS20068354HPVENSG00000012124.17protein_codingCD22NoNo933P20273
Q0EAF5
TVIS20016744HPVENSG00000012124.17protein_codingCD22NoNo933P20273
Q0EAF5
TVIS44018189HTLV-1ENSG00000012124.17protein_codingCD22NoNo933P20273
Q0EAF5
TVIS44033835HTLV-1ENSG00000012124.17protein_codingCD22NoNo933P20273
Q0EAF5
TCGA Plot Options
Drug Information
GeneCD22
DrugBank IDDB04958
Drug NameEpratuzumab
Target IDBE0000183
UniProt IDP20273
Regulation Typeantibody
PubMed IDs16918261; 17530024; 16814387; 33807678
CitationsSteinfeld SD, Youinou P: Epratuzumab (humanised anti-CD22 antibody) in autoimmune diseases. Expert Opin Biol Ther. 2006 Sep;6(9):943-9.@@Leonard JP, Goldenberg DM: Preclinical and clinical evaluation of epratuzumab (anti-CD22 IgG) in B-cell malignancies. Oncogene. 2007 May 28;26(25):3704-13.@@Carnahan J, Stein R, Qu Z, Hess K, Cesano A, Hansen HJ, Goldenberg DM: Epratuzumab, a CD22-targeting recombinant humanized antibody with a different mode of action from rituximab. Mol Immunol. 2007 Feb;44(6):1331-41. Epub 2006 Jun 30.@@Kyriakidis I, Vasileiou E, Rossig C, Roilides E, Groll AH, Tragiannidis A: Invasive Fungal Diseases in Children with Hematological Malignancies Treated with Therapies That Target Cell Surface Antigens: Monoclonal Antibodies, Immune Checkpoint Inhibitors and CAR T-Cell Therapies. J Fungi (Basel). 2021 Mar 5;7(3). pii: jof7030186. doi: 10.3390/jof7030186.
GroupsInvestigational
Direct ClassificationPeptides
SMILES
Pathways
PharmGKB
ChEMBL